Management of Diabetes-Related Cardiovascular Disease: Current Treatment and Future Options

Dear Colleagues,

Cardiovascular disease (CVD) and diabetes mellitus are two of the most prevalent and interrelated chronic conditions worldwide, contributing significantly to global morbidity and mortality. Diabetes is a major risk factor for the development and progression of CVD, and their coexistence presents complex challenges for clinical management and public health. This Special Issue aims to explore the multifaceted relationship between diabetes and cardiovascular disease, focusing on current treatment strategies and emerging therapeutic options.

We invite contributions that address the pathophysiological mechanisms linking diabetes and CVD, novel biomarkers for early detection, and innovative approaches to risk stratification. Topics of interest include lifestyle interventions, pharmacological therapies, advances in glucose-lowering agents with cardiovascular benefits, and integrated care models. Special attention will be given to clinical trials that offer insights into improving patient outcomes.

By bringing together original research articles and reviews, this Special Issue seeks to provide a comprehensive overview of the state-of-the-art in managing diabetes-related cardiovascular complications. Our goal is to foster interdisciplinary dialog and promote evidence-based strategies that can be implemented in diverse healthcare settings.

Dr. Antonio J. Amor
Dr. Tonet Serés-Noriega
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.